BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17401594)

  • 1. Supplier-induced demand: re-examining identification and misspecification in cross-sectional analysis.
    Peacock SJ; Richardson JR
    Eur J Health Econ; 2007 Sep; 8(3):267-77. PubMed ID: 17401594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supplier-induced demand: reconsidering the theories and new Australian evidence.
    Richardson JR; Peacock SJ
    Appl Health Econ Health Policy; 2006; 5(2):87-98. PubMed ID: 16872250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is health care really a luxury?
    Blomqvist AG; Carter RA
    J Health Econ; 1997 Apr; 16(2):207-29. PubMed ID: 10169095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A re-examination of the meaning and importance of supplier-induced demand.
    Labelle R; Stoddart G; Rice T
    J Health Econ; 1994 Oct; 13(3):347-68. PubMed ID: 10138860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An econometric analysis of health care expenditure: a cross-section study of the OECD countries.
    Gerdtham UG; Søgaard J; Andersson F; Jönsson B
    J Health Econ; 1992 May; 11(1):63-84. PubMed ID: 10119757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of supplier induced demand in the health care sector.
    Auster RD; Oaxaca RL
    J Hum Resour; 1981; 16(3):327-42. PubMed ID: 7264294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some economic aspects of the demand for health services.
    Sorkin AL
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Nov; 5(11):610-20. PubMed ID: 2699334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The demand for OTC medicines: some Australian evidence.
    Johnson LW
    Asia Pac J Public Health; 1991; 5(3):228-35. PubMed ID: 1823806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician supply, supplier-induced demand and competition: empirical evidence from a single-payer system.
    Xirasagar S; Lin HC
    Int J Health Plann Manage; 2006; 21(2):117-31. PubMed ID: 16846104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A re-examination of the meaning and importance of supplier-induced demand.
    Pauly MV
    J Health Econ; 1994 Oct; 13(3):369-72. PubMed ID: 10138861
    [No Abstract]   [Full Text] [Related]  

  • 11. More physicians: improved availability or induced demand?
    Carlsen F; Grytten J
    Health Econ; 1998 Sep; 7(6):495-508. PubMed ID: 9809708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the relative fee structure on the use of surgical operations.
    Escarce JJ
    Health Serv Res; 1993 Oct; 28(4):479-502. PubMed ID: 8407339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pooled cross-section analysis of the health care expenditures of the OECD countries.
    Gerdtham UG; Søgaard J; Jönsson B; Andersson F
    Dev Health Econ Public Policy; 1992; 1():287-310. PubMed ID: 10172496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New estimates of elasticity of demand for healthcare in rural China.
    Zhou Z; Su Y; Gao J; Xu L; Zhang Y
    Health Policy; 2011 Dec; 103(2-3):255-65. PubMed ID: 22014842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Econometric analyses of national health expenditures: can positive economics help to answer normative questions?
    McGuire A; Parkin D; Hughes D; Gerard K
    Health Econ; 1993 Jul; 2(2):113-26. PubMed ID: 8261033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Federalism and regional health care expenditures: an empirical analysis for the Swiss cantons.
    Crivelli L; Filippini M; Mosca I
    Health Econ; 2006 May; 15(5):535-41. PubMed ID: 16389663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new test for supplier-inducement and application to the Canadian market for dental care.
    Schaafsma J
    J Health Econ; 1994 Dec; 13(4):407-31. PubMed ID: 10140532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care expenditure and income in Europe.
    Murillo C; Piatecki C; Saez M
    Health Econ; 1993 Jul; 2(2):127-28. PubMed ID: 8261034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the economics of moral hazard need to be revisited? A comment on the paper by John Nyman.
    Blomqvist A
    J Health Econ; 2001 Mar; 20(2):283-8. PubMed ID: 11252375
    [No Abstract]   [Full Text] [Related]  

  • 20. The determinants and effects of health expenditure in developed countries.
    Hitiris T; Posnett J
    J Health Econ; 1992 Aug; 11(2):173-81. PubMed ID: 10122977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.